Loading clinical trials...
Loading clinical trials...
A Phase I/II Multicenter Open-label Dose Escalation Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy
Conditions
Interventions
Recombinant human arylsulfatase A
Locations
5
Australia
The Children's Hospital at Westmead
Westmead, Australia
Rigshospitalet
Copenhagen, Denmark
Hopital de Bicetre
Le Kremlin-Bicêtre, Île-de-France Region, France
Center for Pediatric Clinical Studies
Tübingen, Baden-Wurttemberg, Germany
Osaka University Hospital
Suita, Japan
Start Date
February 2, 2012
Primary Completion Date
January 20, 2017
Completion Date
January 20, 2017
Last Updated
June 14, 2021
NCT07046338
NCT03725670
NCT01372228
NCT01963650
NCT01043640
Lead Sponsor
Shire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions